Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Leaders don’t fail from complexity overload. They fail from pretending it’s simple, then engineering systems that move ...

Over the last 10 months, we established the foundation for new Intel, a more focus and execution-driven company. Along with our next-generation Nova Lake coming at the end of 2026, we now have a ...

Q4 2025 Earnings Call January 22, 2026 5:00 PM ESTCompany ParticipantsJohn Pitzer - Corporate Vice President of Corporate ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, Memorial ...

Tuesday, January 20, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research ...

Kiara Taylor has worked as a financial analyst for more than a decade. Her career has involved a number of financial firms, including Fifth Third Bank, JPMorgan, and Citibank. She has filled a number ...

Intel Corporation (NASDAQ:INTC) Q4 2025 Earnings Call Transcript January 22, 2026 Intel Corporation beats earnings ...

Looking for a research and development job? Check out the BioSpace list of 12 companies hiring life sciences professionals like you.